Protocol Specific Research

CCSG支持研究护士和临床研究助理，致力于进行和完成 由癌症中心项目提出的创新、可行性或原则性临床试验对 SJCRH对儿科肿瘤学的持续贡献。癌症中心领导层致力于特定的方案 只有被认为具有最高优先级的研究和试验才得到该资源的支持。我们的 对以方案为基础的研究的承诺在本拨款第7.0节的汇总表3中说明 申请。该表显示了2005年10月1日至2006年9月30日的指数年为373 在圣犹大，247名患者(66%)接受了治疗临床试验，这是他们最初治疗的一部分。 在圣犹大接受治疗。其中85人(85%)是癌症中心的方案， 其余15%按行业或国家协议执行。此外，在登记参加治疗试验的247名患者中 在指标年内，56人(23%)还接受了一次以上的试验，结果有312人得到治疗 注册人数。这在很大程度上是圣犹大集中努力招募以前接受过治疗的患者到圣犹大的结果。 为我们的L/11期发展治疗计划颁奖。最后，出席会议的373名患者 索引年还促成了549名非治疗性注册，在此期间共有861名礼仪注册 索引年份。

CCSG support of research nurses and clinical research associates dedicated to the conduct and completion of innovative, feasibility or proof-of-principle clinical trials proposed by Cancer Center Programs is critical for SJCRH's continued contribution to pediatric oncology. The Cancer Center leadership is dedicated to protocolspecific research and only trials considered to be of the highest priority are supported by this resource. Our commitment to protocol-based research is illustrated in Summary Table 3 in section 7.0 of this grant application. That table shows that for the index year of October 1, 2005 through September 30, 2006, of 373 patients presenting to St. Jude, 247 (66%) were treated on a therapeutic clinical trial as part of their initial treatment at St. Jude. Eighty-five (85%) of these enrollments were Cancer Center protocols, with the remaining 15% on industry or national protocols. In addition, of the 247 patients enrolling on therapeutic trials during the index year, 56 (23%) were also treated on more than one trial, resulting in 312 therapeutic enrollments. This is largely a result of St. Jude's concentrated effort to recruit previously treated patients to St. Jude for our Phase l/ll Developmental Therapeutics Program. Finally, the 373 patients presenting during the index year also contributed to 549 non-therapeutic enrollments, for a total of 861 protocol enrollments during the index year.